Adenovirus antibody (substance)

In vivo regenerative gene therapy is a promising approach for bone regeneration and can help to address cell-source limitations… Expand

Although replication-competent viruses have been developed to treat cancers, their cytotoxic effects are insufficient, as… Expand

Dendritic cells (DCs) are powerful antigen-presenting cells that process antigens and present peptide epitopes in the context of… Expand

The present study investigated a novel approach for gene therapy of heart valve disease and vascular disorders. We formulated and… Expand

P53-based immunization is an attractive approach to cancer immunotherapy due to the accumulation of p53 protein in tumor, but not… Expand

Tumor necrosis factor-α (TNF-α) is well recognized for its role in mediating innate immune responses. However, the mechanisms of… Expand

Recombinant adenoviral vectors are attractive in the context of cancer gene therapy because they are capable of delivering genes… Expand

We have investigated the humoral immune response to E1-deleted adenovirus vectors encoding the lacZ gene introduced into the… Expand

Recent advances in molecular biology have made gene therapy for cancer feasible in clinical trials. Although recombinant… Expand

Ad CFTR, a replication-deficient adenovirus expressing the human cystic fibrosis transmembrane conductance regulator (CFTR), was… Expand